Peripartum cardiomyopathy and HELLP syndrome in a previously healthy multiparous woman: A case report.
HELLP syndrome
peripartal cardiomyopathy
peripartum cardiomyopathy
placental abruption
postpartum
postpartum cardiomyopathy
postpartum hemorrhage
pregnancy complications
Journal
SAGE open medical case reports
ISSN: 2050-313X
Titre abrégé: SAGE Open Med Case Rep
Pays: England
ID NLM: 101638686
Informations de publication
Date de publication:
2020
2020
Historique:
received:
13
06
2020
accepted:
11
11
2020
entrez:
11
1
2021
pubmed:
12
1
2021
medline:
12
1
2021
Statut:
epublish
Résumé
Peripartum cardiomyopathy is a type of dilated cardiomyopathy in which the exact etiology is uncertain. HELLP syndrome is characterized by a constellation of different clinical and laboratory findings, including hemolysis, elevated liver enzymes, and low platelets. Few case reports exist detailing successful diagnosis and management of postpartum HELLP syndrome, peripartum cardiomyopathy, and multisystem organ failure in a previously healthy woman. We herein report the case of a 39-year-old multiparous female with mild gestational hypertension, who presented in the third trimester with vaginal bleeding and was subsequently suspected to have intrapartum placental abruption leading to immediate Cesarean section, complicated by massive postpartum hemorrhage, necessitating care in the intensive care unit. HELLP syndrome, disseminated intravascular coagulation, and acute kidney injury requiring hemodialysis subsequently developed along with respiratory failure and peripartum cardiomyopathy. After diagnosis and proper management, the patient made a full recovery. Peripartum cardiomyopathy should remain on the differential for women with heart failure symptoms.
Identifiants
pubmed: 33425357
doi: 10.1177/2050313X20979288
pii: 10.1177_2050313X20979288
pmc: PMC7758651
doi:
Types de publication
Case Reports
Langues
eng
Pagination
2050313X20979288Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Circulation. 2018 Nov 20;138(21):2359-2366
pubmed: 30021846
Curr Hypertens Rep. 2018 Jul 3;20(8):69
pubmed: 29971645
Nature. 2012 May 09;485(7398):333-8
pubmed: 22596155
Clin Rheumatol. 2009 Mar;28(3):343-5
pubmed: 19082775
Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):120-3
pubmed: 15989990
J Perinatol. 1999 Mar;19(2):138-43
pubmed: 10642976
J Matern Fetal Neonatal Med. 2020 Jun 10;:1-11
pubmed: 32519919
Eur J Obstet Gynecol Reprod Biol. 2010 Jul;151(1):110-1
pubmed: 20444535
Obstet Gynecol. 1999 Aug;94(2):311-6
pubmed: 10432149
Circ J. 2011;75(8):1975-81
pubmed: 21617320
Masui. 2011 Jan;60(1):107-10
pubmed: 21348261
J Am Heart Assoc. 2014 Jun 04;3(3):e001056
pubmed: 24901108
Ups J Med Sci. 2013 Mar;118(1):51-3
pubmed: 23033875
Circulation. 2016 Apr 5;133(14):1397-409
pubmed: 27045128